Short-term and long-term prognoses in AChR-Ab positive very-late-onset myasthenia gravis patients

Very-late-onset myasthenia gravis (VLOMG) refers to myasthenia gravis (MG) with onset at age 65 or older. Current research on VLOMG prognosis remains limited, especially regarding factors influencing outcomes. To identify the clinical factors that affect the short- and long-term prognosis of MG pati...

Full description

Saved in:
Bibliographic Details
Published in:Therapeutic advances in neurological disorders 2025, Vol.18, p.17562864241309793
Main Authors: Xie, Nairong, Liu, Qing, Wen, Qi, Wang, Yaye, Liu, Haoran, Jiang, Yuting, Lu, Yan, Di, Li, Wang, Min, Zhu, Wenjia, Wen, Xinmei, Zhang, Xuxiang, Shen, Xin-Ming, Da, Yuwei
Format: Article
Language:English
Subjects:
Original Research
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Very-late-onset myasthenia gravis (VLOMG) refers to myasthenia gravis (MG) with onset at age 65 or older. Current research on VLOMG prognosis remains limited, especially regarding factors influencing outcomes. To identify the clinical factors that affect the short- and long-term prognosis of MG patients with an onset age ⩾65 years. This was a single-center, retrospective cohort study of AChR-ab positive VLOMG patients, classified into two subgroups based on age of onset: sub-very-late-onset MG (S-VLOMG, onset age ⩾65 and
ISSN:1756-2856
1756-2864
1756-2864
DOI:10.1177/17562864241309793